Search Results

Filter
  • 1-10 of  515,335 results for "%22COVID-19 vaccines%22"

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Reported COVID-19 vaccines side effects among Algerian athletes: a comparison between inactivated virus, adenoviral vector, and mRNA COVID-19 vaccines.

  • Authors : Oudjedi A; Institute of Science and Techniques of Physical and Sports Activities, Department of Physical Education and Sports, University of Oum El Bouaghi, Oum El Bouaghi, Algeria.; Allali A

Subjects: COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/adverse effects ; COVID-19*/COVID-19*/COVID-19*/prevention & control; Female

  • Source: The Physician and sportsmedicine [Phys Sportsmed] 2024 Apr; Vol. 52 (2), pp. 134-146. Date of Electronic Publication: 2023 Mar 06.Publisher: Taylor & Francis Country of Publication: England NLM ID: 0427461 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

[Effectiveness and safety of COVID-19 vaccines in healthcare workers in Buenos Aires City, Argentina.]

Subjects: COVID-19 Vaccines* ; COVID-19*; Humans

  • Source: Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina) [Rev Fac Cien Med Univ Nac Cordoba] 2024 Mar 27; Vol. 81 (1), pp. 115-127. Date of Electronic Publication: 2024 Mar Publisher: Universidad Nacional De Cordoba, Facultad De Ciencias Medicas Country of Publication: Argentina NLM ID: 8303003 Publication Model: Electronic

Record details

×
Academic Journal

COVID-19 vaccines breakthrough infection and adverse reactions in medical students: a nationwide survey in Iran.

  • Authors : Allahgholipour A; Student Research Committee, School of Medical Education and Learning Technologies, Shahid Beheshti University of Medical Sciences, Tehran, Iran.; Safavi-Naini SAA

Subjects: Breakthrough Infections* ; COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control COVID-19 breakthrough infectionsSARS-CoV-2 variants

  • Source: Frontiers in public health [Front Public Health] 2024 Mar 13; Vol. 12, pp. 1348015. Date of Electronic Publication: 2024 Mar 13 (Print Publication: 2024).Publisher: Frontiers Editorial Office Country of Publication: Switzerland NLM ID: 101616579 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

SARS-CoV-2 infection triggers more potent antibody-dependent cellular cytotoxicity (ADCC) responses than mRNA-, vector-, and inactivated virus-based COVID-19 vaccines.

  • Authors : Zedan HT; Infectious Diseases Department, Biomedical Research Center, Research Complex, Qatar University, Doha, Qatar.; Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar.

Subjects: COVID-19 Vaccines* ; COVID-19*/COVID-19*/COVID-19*/prevention & control; Humans SARS-CoV-2 variants

  • Source: Journal of medical virology [J Med Virol] 2024 Mar; Vol. 96 (3), pp. e29527.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7705876 Publication Model: Print Cited Medium: Internet ISSN: 1096-9071

Record details

×
Academic Journal

Adverse events following immunization reported with COVID-19 vaccines in Burkina Faso: Analysis of spontaneous reports

  • Authors : Sawadogo R; Institut supérieur des sciences de la santé (IN.S.SA), Université Nazi BONI (UNB), Bobo-Dioulasso, Burkina Faso; Agence nationale de régulation pharmaceutique (ANRP), ministère de la Santé, Ouagadougou, Burkina Faso.

Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/adverse effects

  • Source: Sante publique (Vandoeuvre-les-Nancy, France) [Sante Publique] 2024 Feb 23; Vol. 35 (6), pp. 149-159.Publisher: SFSP ; Rennes : ENSP Country of Publication: France NLM ID: 9216153 Publication Model: Print Cited Medium: Print ISSN: 0995-3914

Record details

×
Academic Journal

How the case counting window affected vaccine efficacy calculations in randomized trials of COVID-19 vaccines.

  • Authors : Doshi P; Department of Practice, Sciences, and Health Outcomes Research, University of Maryland School of Pharmacy, Baltimore, Maryland, USA.; Fung K

Subjects: COVID-19 Vaccines* ; COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control

  • Source: Journal of evaluation in clinical practice [J Eval Clin Pract] 2024 Feb; Vol. 30 (1), pp. 105-106. Date of Electronic Publication: 2023 Jul 15.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9609066 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Effectiveness and safety of COVID-19 vaccines on maternal and perinatal outcomes: a systematic review and meta-analysis.

Subjects: COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/adverse effects ; COVID-19*/COVID-19*/COVID-19*/prevention & control; Infant, Newborn

  • Source: BMJ global health [BMJ Glob Health] 2024 Apr 04; Vol. 9 (4). Date of Electronic Publication: 2024 Apr 04.Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101685275 Publication Model: Electronic Cited Medium: Print ISSN:

Record details

×
Academic Journal

Attitudes Toward COVID-19 Vaccines Among Pregnant and Recently Pregnant Individuals.

  • Authors : Williams JTB; Ambulatory Care Services, Denver Health and Hospitals, Denver, Colorado.; Department of Pediatrics, University of Colorado School of Medicine, Aurora.

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19 Vaccines* ; Health Knowledge, Attitudes, Practice*

  • Source: JAMA network open [JAMA Netw Open] 2024 Apr 01; Vol. 7 (4), pp. e245479. Date of Electronic Publication: 2024 Apr 01.Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet

Record details

×
Editorial & Opinion

Editorial: Prophylactic efficacy and safety of COVID-19 vaccines in preventing disease caused by various SARS CoV-2 variants.

  • Authors : Mousa HA; College of Medicine, University of Basrah, Basrah, Iraq.; Ansari MA

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/therapeutic use ; SARS-CoV-2*SARS-CoV-2 variants

  • Source: Frontiers in cellular and infection microbiology [Front Cell Infect Microbiol] 2024 Mar 13; Vol. 14, pp. 1384601. Date of Electronic Publication: 2024 Mar 13 (Print Publication:Publisher: Frontiers Media SA Country of Publication: Switzerland NLM ID: 101585359 Publication Model: eCollection Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Effectiveness of COVID-19 vaccines among children 6-11 years against hospitalization during Omicron predominance in Malaysia.

  • Authors : Jayaraj VJ; Sector for Biostatistics & Data Repository, National Institutes of Health, Ministry of Health Malaysia, Selangor, Malaysia. .; Husin M

Subjects: COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/therapeutic use ; COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control

  • Source: Scientific reports [Sci Rep] 2024 Mar 08; Vol. 14 (1), pp. 5690. Date of Electronic Publication: 2024 Mar 08.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  515,335 results for "%22COVID-19 vaccines%22"